![]()
|
|
||||||||
J Biol Chem, Vol. 274, Issue 50, 35469-35474, December 10, 1999
,
From the Neuroscience Research Institute, Departments of Medicine
and Cellular and Molecular Medicine, University of Ottawa, Ottawa,
Canada K1H 8M5 and the ¶ Department of Pharmacology and
Therapeutics, McGill University, Montreal, Canada H3G 1Y6
The 5-HT1A receptor is implicated in depression
and anxiety. This receptor couples to Gi proteins to
inhibit adenylyl cyclase (AC) activity but can stimulate AC in tissues
(e.g. hippocampus) that express ACII. The role of ACII in
receptor-mediated stimulation of cAMP formation was examined in HEK-293
cells transfected with the 5-HT1A receptor, which mediated inhibition
of basal and Gs-induced cAMP formation in the absence of
ACII. In cells cotransfected with 5-HT1A receptor and ACII plasmids,
5-HT1A agonists induced a 1.5-fold increase in cAMP level.
Cotransfection of 5-HT1A receptor, ACII, and G
i2, but
not G
i1, G
i3, or G
o,
resulted in an agonist-independent 6-fold increase in the basal cAMP
level, suggesting that Gi2 preferentially coupled the
receptor to ACII. The 5-HT1B receptor also constitutively activated
ACII. Constitutive activity of the 5-HT1A receptor was blocked by
pertussis toxin and the G
antagonist,
CT, suggesting an
important role for G
-mediated activation of ACII. The Thr-149
Ala mutation in the second intracellular domain of the 5-HT1A receptor
disrupted G
-selective activation of ACII. Spontaneous 5-HT1A
receptor activity was partially attenuated by 5-HT1A receptor partial
agonists with anxiolytic activity (e.g. buspirone and flesinoxan) but was not altered by full agonists or antagonists. Thus,
anxiolytic activity may involve inhibition of spontaneous 5-HT1A
receptor activity.
Novartis/MRC Michael Smith Chair in Neurosciences. To whom
correspondence should be addressed: Neuroscience Research Institute, University of Ottawa, 451 Smyth Rd., Ottawa, Canada K1H 8M5. Tel.: 613-562-5800, ext. 8307; Fax: 613-562-5403; E-mail: palbert@
uottawa.ca.
§
MRC Scholar.
Supported by the Ministry of Iran and a Schizophrenia Society
of Canada scholarship.
This article has been cited by other articles:
![]() |
C. M. la Cour, S. El Mestikawy, N. Hanoun, M. Hamon, and L. Lanfumey Regional Differences in the Coupling of 5-Hydroxytryptamine-1A Receptors to G Proteins in the Rat Brain Mol. Pharmacol., September 1, 2006; 70(3): 1013 - 1021. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Kushwaha, S. C. Harwood, A. M. Wilson, M. Berger, L. H. Tecott, B. L. Roth, and P. R. Albert Molecular Determinants in the Second Intracellular Loop of the 5-Hydroxytryptamine-1A Receptor for G-Protein Coupling Mol. Pharmacol., May 1, 2006; 69(5): 1518 - 1526. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. R. Albert and S. Lemonde 5-HT1A Receptors, Gene Repression, and Depression: Guilt by Association Neuroscientist, December 1, 2004; 10(6): 575 - 593. [Abstract] [PDF] |
||||
![]() |
H. Mao, Q. Zhao, M. Daigle, M. H. Ghahremani, P. Chidiac, and P. R. Albert RGS17/RGSZ2, a Novel Regulator of Gi/o, Gz, and Gq Signaling J. Biol. Chem., June 18, 2004; 279(25): 26314 - 26322. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Idzko, E. Panther, C. Stratz, T. Muller, H. Bayer, G. Zissel, T. Durk, S. Sorichter, F. Di Virgilio, M. Geissler, et al. The Serotoninergic Receptors of Human Dendritic Cells: Identification and Coupling to Cytokine Release J. Immunol., May 15, 2004; 172(10): 6011 - 6019. [Abstract] [Full Text] [PDF] |
||||
![]() |
M.-C. Buhot, M. Wolff, N. Benhassine, P. Costet, R. Hen, and L. Segu Spatial Learning in the 5-HT1B Receptor Knockout Mouse: Selective Facilitation/Impairment Depending on the Cognitive Demand Learn. Mem., November 1, 2003; 10(6): 466 - 477. [Abstract] [Full Text] [PDF] |
||||
![]() |
X.-M. Ou, S. Lemonde, H. Jafar-Nejad, C. D. Bown, A. Goto, A. Rogaeva, and P. R. Albert Freud-1: A Neuronal Calcium-Regulated Repressor of the 5-HT1A Receptor Gene J. Neurosci., August 13, 2003; 23(19): 7415 - 7425. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Y. Carroll, A. Stolle, P. M. Beart, A. Voerste, I. Brabet, F. Mauler, C. Joly, H. Antonicek, J. Bockaert, T. Müller, et al. BAY36-7620: A Potent Non-Competitive mGlu1 Receptor Antagonist with Inverse Agonist Activity. Mol. Pharmacol., April 16, 2001; 59(5): 965 - 973. [Abstract] [Full Text] |
||||
![]() |
X. Wu, N. Kushwaha, P. R. Albert, and N. J. Penington A critical protein kinase C phosphorylation site on the 5-HT1A receptor controlling coupling to N-type calcium channels J. Physiol., January 1, 2002; 538(1): 41 - 51. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |